Page last updated: 2024-11-02

pirenzepine and Heart Failure

pirenzepine has been researched along with Heart Failure in 3 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"We studied the effect of intravenous pirenzepine (3 mg) in normal subjects (n=15, 43+/-16 years old) and in patients with chronic heart failure (n=15, 61+/-12 years old) to assess the effect of low-dose pirenzepine on vagal activity."7.70Paradoxical effects of pirenzepine on parasympathetic activity in chronic heart failure and control. ( Furutani, Y; Hayano, T; Ikeda, Y; Matsuzaki, M; Shimizu, A; Ueyama, T; Yamagata, T; Yamamoto, T, 1999)
"The pruritus was also based on chronic, self-induced skin lesions due to aggressive disinfection and tearing out of body hair."5.32[A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy]. ( Freudenmann, RW, 2003)
"We studied the effect of intravenous pirenzepine (3 mg) in normal subjects (n=15, 43+/-16 years old) and in patients with chronic heart failure (n=15, 61+/-12 years old) to assess the effect of low-dose pirenzepine on vagal activity."3.70Paradoxical effects of pirenzepine on parasympathetic activity in chronic heart failure and control. ( Furutani, Y; Hayano, T; Ikeda, Y; Matsuzaki, M; Shimizu, A; Ueyama, T; Yamagata, T; Yamamoto, T, 1999)
"The pruritus was also based on chronic, self-induced skin lesions due to aggressive disinfection and tearing out of body hair."1.32[A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy]. ( Freudenmann, RW, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freudenmann, RW1
Hayano, T1
Shimizu, A1
Ikeda, Y1
Yamamoto, T1
Yamagata, T1
Ueyama, T1
Furutani, Y1
Matsuzaki, M1
Engelhardt, D1
Karl, R1
Kolb, HJ1
Inthorn, D1
König, N1
Büll, U1
Hölzel, D1

Trials

1 trial available for pirenzepine and Heart Failure

ArticleYear
[Comparison between cimetidine-pirenzepine and antacids for the prevention of stress hemorrhage in intensive care patients. A controlled clinical study on 125 patients].
    Deutsche medizinische Wochenschrift (1946), 1985, Jun-07, Volume: 110, Issue:23

    Topics: Adult; Aged; Antacids; Benzodiazepinones; Chromium Radioisotopes; Cimetidine; Clinical Trials as Top

1985

Other Studies

2 other studies available for pirenzepine and Heart Failure

ArticleYear
[A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy].
    Der Nervenarzt, 2003, Volume: 74, Issue:7

    Topics: Aged; Antipsychotic Agents; Benzodiazepines; Comorbidity; Delusions; Dementia, Vascular; Drug Intera

2003
Paradoxical effects of pirenzepine on parasympathetic activity in chronic heart failure and control.
    International journal of cardiology, 1999, Volume: 68, Issue:1

    Topics: Adult; Analysis of Variance; Case-Control Studies; Chronic Disease; Echocardiography; Female; Heart

1999